FDA approves gedatolisib for HR+/HER2- breast cancer. Learn about the VIKTORIA-1 trial, dosing, and nursing strategies for managing stomatitis.
Sara A. Hurvitz, MD, FACP
Advertisement
Articles by Sara A. Hurvitz, MD, FACP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Gedatolisib for HR+/HER2- Metastatic Breast Cancer
2
FDA Grants Traditional Approval to Selpercatinib for RET-Fusion Solid Tumors
3
FDA Approves First On-Body Injector for Multiple Myeloma Treatment
4
Multiple Myeloma Care: Innovative Nursing Strategies and Patient Support
5